Kera Capital Partners Inc. purchased a new position in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 3,191 shares of the company’s stock, valued at approximately $287,000.
Other large investors also recently bought and sold shares of the company. Thrivent Financial for Lutherans bought a new stake in shares of DocuSign during the second quarter worth $115,795,000. Pacer Advisors Inc. increased its stake in DocuSign by 77.9% in the 2nd quarter. Pacer Advisors Inc. now owns 3,519,969 shares of the company’s stock worth $188,318,000 after buying an additional 1,541,816 shares during the period. KBC Group NV lifted its holdings in DocuSign by 209.8% during the 3rd quarter. KBC Group NV now owns 1,156,874 shares of the company’s stock valued at $71,830,000 after buying an additional 783,419 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its position in DocuSign by 42.4% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,459,580 shares of the company’s stock valued at $90,625,000 after buying an additional 434,312 shares during the period. Finally, International Assets Investment Management LLC grew its stake in DocuSign by 5,660.8% in the 3rd quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock worth $27,252,000 after acquiring an additional 431,295 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.
Analysts Set New Price Targets
DOCU has been the subject of several research analyst reports. Robert W. Baird lifted their price target on shares of DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. JPMorgan Chase & Co. lifted their target price on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research report on Tuesday, December 3rd. UBS Group increased their price target on DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a report on Friday, December 6th. Finally, Wells Fargo & Company upped their price objective on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $92.45.
Insider Buying and Selling
In related news, insider Robert Chatwani sold 14,800 shares of the business’s stock in a transaction on Wednesday, December 18th. The stock was sold at an average price of $97.76, for a total transaction of $1,446,848.00. Following the transaction, the insider now directly owns 73,414 shares in the company, valued at $7,176,952.64. The trade was a 16.78 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Allan C. Thygesen sold 7,764 shares of the company’s stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $69.95, for a total value of $543,091.80. Following the transaction, the chief executive officer now directly owns 107,825 shares in the company, valued at $7,542,358.75. This represents a 6.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 693,537 shares of company stock worth $66,575,817 in the last 90 days. 1.66% of the stock is owned by corporate insiders.
DocuSign Stock Performance
DOCU stock opened at $89.60 on Friday. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The firm has a market cap of $18.10 billion, a price-to-earnings ratio of 18.47, a PEG ratio of 8.17 and a beta of 0.88. The firm has a 50-day simple moving average of $88.76 and a two-hundred day simple moving average of $70.27.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
- Five stocks we like better than DocuSign
- Why Invest in 5G? How to Invest in 5G Stocks
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Top Stocks Investing in 5G Technology
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- How to buy stock: A step-by-step guide for beginners
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.